Who Paid My Doc
Swan-Ganz
Device Minimally Invasive Hemodynamic Monitoring
PDI 00690103000405
General payments
$26,746
Research payments
$1,236,035
Through program year 2025, $26,746 in general payments and $1,236,035 in research payments were reported against Swan-Ganz (Minimally Invasive Hemodynamic Monitoring).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $8,997 | 81 |
| 2024 | General | $1,803 | 64 |
| 2023 | General | $5,667 | 86 |
| 2023 | Research | $8,000 | 1 |
| 2022 | General | $7,461 | 41 |
| 2022 | Research | $104,666 | 15 |
| 2021 | General | $2,817 | 20 |
| 2021 | Research | $1,123,369 | 22 |
Breakdown
The top 5 of 75 recipients; each share is of general payments naming this product in 2025.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 14 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
292 general · 38 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.